169 related articles for article (PubMed ID: 18674899)
1. Synthesis and antiviral properties of some polyphenols related to Salvia genus.
Queffélec C; Bailly F; Mbemba G; Mouscadet JF; Hayes S; Debyser Z; Witvrouw M; Cotelle P
Bioorg Med Chem Lett; 2008 Aug; 18(16):4736-40. PubMed ID: 18674899
[TBL] [Abstract][Full Text] [Related]
2. A potent anti-HIV polyphenol from Salvia yunnanensis.
Zhang ZF; Chen HS; Peng ZG; Li ZR; Jiang JD
J Asian Nat Prod Res; 2008; 10(3-4):273-7. PubMed ID: 18335344
[TBL] [Abstract][Full Text] [Related]
3. N-(4-Fluorobenzyl)-3-hydroxy-9,9-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a]pyrimidine-2-carboxamides a novel class of potent HIV-1 integrase inhibitors.
Petrocchi A; Jones P; Rowley M; Fiore F; Summa V
Bioorg Med Chem Lett; 2009 Aug; 19(15):4245-9. PubMed ID: 19523819
[TBL] [Abstract][Full Text] [Related]
4. Efficient synthesis and utilization of phenyl-substituted heteroaromatic carboxylic acids as aryl diketo acid isosteres in the design of novel HIV-1 integrase inhibitors.
Zeng LF; Zhang HS; Wang YH; Sanchez T; Zheng YT; Neamati N; Long YQ
Bioorg Med Chem Lett; 2008 Aug; 18(16):4521-4. PubMed ID: 18662877
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines.
Xia CN; Li HB; Liu F; Hu WX
Bioorg Med Chem Lett; 2008 Dec; 18(24):6553-7. PubMed ID: 18952420
[TBL] [Abstract][Full Text] [Related]
6. 4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors.
Pace P; Spieser SA; Summa V
Bioorg Med Chem Lett; 2008 Jul; 18(14):3865-9. PubMed ID: 18595690
[TBL] [Abstract][Full Text] [Related]
7. Naphthoxazepine inhibitors of HIV-1 integrase: synthesis and biological evaluation.
Garofalo A; Grande F; Brizzi A; Aiello F; Dayam R; Neamati N
ChemMedChem; 2008 Jun; 3(6):986-90. PubMed ID: 18383063
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of potent antitumor and antiviral benzofuran derivatives.
Galal SA; Abd El-All AS; Abdallah MM; El-Diwani HI
Bioorg Med Chem Lett; 2009 May; 19(9):2420-8. PubMed ID: 19345581
[TBL] [Abstract][Full Text] [Related]
9. The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore.
Johns BA; Weatherhead JG; Allen SH; Thompson JB; Garvey EP; Foster SA; Jeffrey JL; Miller WH
Bioorg Med Chem Lett; 2009 Mar; 19(6):1802-6. PubMed ID: 19217781
[TBL] [Abstract][Full Text] [Related]
10. The total synthesis of fukiic acid, an HIV-1 integrase inhibitor.
Queffélec C; Bailly F; Mbemba G; Mouscadet JF; Debyser Z; Witvrouw M; Cotelle P
Eur J Med Chem; 2008 Oct; 43(10):2268-71. PubMed ID: 18243421
[TBL] [Abstract][Full Text] [Related]
11. Anti-HBV agents. Part 1: Synthesis of alisol A derivatives: a new class of hepatitis B virus inhibitors.
Zhang Q; Jiang ZY; Luo J; Cheng P; Ma YB; Zhang XM; Zhang FX; Zhou J; Chen JJ
Bioorg Med Chem Lett; 2008 Aug; 18(16):4647-50. PubMed ID: 18644720
[TBL] [Abstract][Full Text] [Related]
12. 1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position.
Johns BA; Weatherhead JG; Allen SH; Thompson JB; Garvey EP; Foster SA; Jeffrey JL; Miller WH
Bioorg Med Chem Lett; 2009 Mar; 19(6):1807-10. PubMed ID: 19217284
[TBL] [Abstract][Full Text] [Related]
13. 10-Hydroxy-7,8-dihydropyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-diones: potent, orally bioavailable HIV-1 integrase strand-transfer inhibitors with activity against integrase mutants.
Wiscount CM; Williams PD; Tran LO; Embrey MW; Fisher TE; Sherman V; Homnick CF; Donnette Staas D; Lyle TA; Wai JS; Vacca JP; Wang Z; Felock PJ; Stillmock KA; Witmer MV; Miller MD; Hazuda DJ; Day AM; Gabryelski LJ; Ecto LT; Schleif WA; DiStefano DJ; Kochansky CJ; Anari MR
Bioorg Med Chem Lett; 2008 Aug; 18(16):4581-3. PubMed ID: 18657970
[TBL] [Abstract][Full Text] [Related]
14. Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease.
Pompei M; Francesco ME; Koch U; Liverton NJ; Summa V
Bioorg Med Chem Lett; 2009 May; 19(9):2574-8. PubMed ID: 19328685
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and HIV-1 integrase inhibitory activities of caffeic acid dimers derived from Salvia officinalis.
Bailly F; Queffelec C; Mbemba G; Mouscadet JF; Cotelle P
Bioorg Med Chem Lett; 2005 Nov; 15(22):5053-6. PubMed ID: 16183277
[TBL] [Abstract][Full Text] [Related]
16. Biologically-validated HIV integrase inhibitors with nucleobase scaffolds: structure, synthesis, chemical biology, molecular modeling, and antiviral activity.
Nair V; Uchil V; Chi G; Dams I; Cox A; Seo B
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):665-8. PubMed ID: 18066876
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition.
Schnute ME; Brideau RJ; Collier SA; Cudahy MM; Hopkins TA; Knechtel ML; Oien NL; Sackett RS; Scott A; Stephan ML; Wathen MW; Wieber JL
Bioorg Med Chem Lett; 2008 Jul; 18(14):3856-9. PubMed ID: 18595689
[TBL] [Abstract][Full Text] [Related]
18. Radical-scavenging polyphenols: new strategies for their synthesis.
Bovicelli P
J Pharm Pharmacol; 2007 Dec; 59(12):1703-10. PubMed ID: 18053333
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.
Billamboz M; Bailly F; Barreca ML; De Luca L; Mouscadet JF; Calmels C; Andréola ML; Witvrouw M; Christ F; Debyser Z; Cotelle P
J Med Chem; 2008 Dec; 51(24):7717-30. PubMed ID: 19053754
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and SAR studies of novel and highly active tri-cyclic HIV integrase inhibitors.
Jin H; Cai RZ; Schacherer L; Jabri S; Tsiang M; Fardis M; Chen X; Chen JM; Kim CU
Bioorg Med Chem Lett; 2006 Aug; 16(15):3989-92. PubMed ID: 16723225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
